Cargando…
Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response
BACKGROUND: Ionizing radiation (IR) therapy is the standard first-line treatment for newly diagnosed patients with glioblastoma (GBM), the most common and malignant primary brain tumor. However, the effects of IR are limited due to the aberrant radioresistance of GBM. METHODS: Transcriptome analysis...
Autores principales: | Wang, Yinfang, Hou, Yanli, Zhang, Weiwei, Alvarez, Angel A., Bai, Yongrui, Hu, Bo, Cheng, Shi-Yuan, Yang, Kun, Li, Yanxin, Feng, Haizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451284/ https://www.ncbi.nlm.nih.gov/pubmed/30953555 http://dx.doi.org/10.1186/s13046-019-1151-x |
Ejemplares similares
-
Correction to: Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response
por: Wang, Yinfang, et al.
Publicado: (2019) -
Correction to: Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response
por: Wang, Yinfang, et al.
Publicado: (2019) -
Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling
por: Hou, Yanli, et al.
Publicado: (2021) -
Pronounced expression of the lipolytic inhibitor G0/G1 Switch Gene 2 (G0S2) in adipose tissue from brown bears (Ursus arctos) prior to hibernation
por: Jessen, Niels, et al.
Publicado: (2016) -
Lipolytic actions of secretin in mouse adipocytes
por: Sekar, Revathi, et al.
Publicado: (2014)